참고문헌
- Dauvilliers Y. Insomnia in patients with neurodegenerative conditions. Sleep Med. 2007;8 Suppl 4:S27-34.
- Yesavage JA, Friedman L, Ancoli-israel S, Bliwise D, Singer C, Vitiello MV, Monjan AA, Lebowitz B. Development of diagnostic criteria for defining sleep disturbance in Alzheimer's disease. J Geriatr Psychiatry Neurol. 2003;16:131-139. https://doi.org/10.1177/0891988703255684
- Hope T, Keene J, Gedling K, Fairburn CG, Jacoby R. Predictors of institutionalization for people with dementia living at home with a carer. Int J Geriatr Psychiatry. 1998;13:682-690. https://doi.org/10.1002/(SICI)1099-1166(1998100)13:10<682::AID-GPS847>3.0.CO;2-Y
- Thompson S, Lanctôt KL, Herrmann N. The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease. Expert Opin Drug Saf. 2004;3:425-440. https://doi.org/10.1517/14740338.3.5.425
- Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy. Drugs Aging. 2004;21:453-478. https://doi.org/10.2165/00002512-200421070-00004
- Rogers SL, Doody RS, Mohs RC, Friedhoff LT. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med. 1998;158:1021-1031. https://doi.org/10.1001/archinte.158.9.1021
- Stahl SM, Markowitz JS, Papadopoulos G, Sadik K. Examination of nighttime sleep-related problems during double-blind, placebo-controlled trials of galantamine in patients with Alzheimer's disease. Curr Med Res Opin. 2004;20:517-524. https://doi.org/10.1185/030079904125003214
- Ancoli-Israel S, Amatniek J, Ascher S, Sadik K, Ramaswamy K. Effects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-to-head, randomized pilot study. Alzheimer Dis Assoc Disord. 2005;19:240-245. https://doi.org/10.1097/01.wad.0000189052.48688.36
- Schredl M, Weber B, Leins ML, Heuser I. Donepezil-induced REM sleep augmentation enhances memory performance in elderly, healthy persons. Exp Gerontol. 2001;36:353-361. https://doi.org/10.1016/S0531-5565(00)00206-0
- Guay DR. Drug forecast: memantine, prototype of a new approach to treatment of dementia. Consult Pharm. 2003;18:625-634.
- Ishida T, Kamei C. Characteristic effects of anti-dementia drugs on rat sleep patterns. J Pharmacol Sci. 2009;109:449-455 https://doi.org/10.1254/jphs.08229FP
- Ishida T, Obara Y, Kamei C. Studies on wakefulness-promoting effect of memantine in rats. Behav Brain Res. 2010;206:274-278. https://doi.org/10.1016/j.bbr.2009.09.025
- Jung JY. Characterization of vibration signal patterns for rat behaviors using specially designed vibration sensors, Kyungpook National University Graduate School. 2010; MS Thesis.
- Kwon DH, Won SH, Kim KM, Chang SM, Kim SH, Lee MG. Effect of caffeine on sleep and EEG spectra in rats. J Korean Soc Biol Ther Psychiatry. 2006;12:252-267.
- Lee MG, Kim M, Roh M, Jang IS, Won SH. Differences between physostigmine- and yohimbine-induced states are visualized in canonical space constructed from EEG during natural sleepwake cycle in rats. Exp Neurobiol. 2011;20:54-65. https://doi.org/10.5607/en.2011.20.1.54
- Farlow MR, Cummings JL. Effective pharmacologic management of Alzheimer's disease. Am J Med. 2007;120:388-397. https://doi.org/10.1016/j.amjmed.2006.08.036
- Blesa R. Galantamine: therapeutic effects beyond cognition. Dement Geriatr Cogn Disord. 2000;11 Suppl 1:28-34. https://doi.org/10.1159/000051229
- Geerts H. Indicators of neuroprotection with galantamine. Brain Res Bull. 2005;64:519-524. https://doi.org/10.1016/j.brainresbull.2004.11.002
- Hanania T, Zahniser NR. Locomotor activity induced by noncompetitive NMDA receptor antagonists versus dopamine transporter inhibitors: opposite strain differences in inbred long-sleep and short-sleep mice. Alcohol Clin Exp Res. 2002;26:431-440. https://doi.org/10.1111/j.1530-0277.2002.tb02558.x
피인용 문헌
- Longitudinal Dynamics of 3-Dimensional Components of Selfhood After Severe Traumatic Brain Injury: A qEEG Case Study vol.48, pp.5, 2012, https://doi.org/10.1177/1550059417696180
- Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use vol.43, pp.6, 2012, https://doi.org/10.1007/s40264-020-00915-6
- Modulation of arousal and sleep/wake architecture by M1 PAM VU0453595 across young and aged rodents and nonhuman primates vol.45, pp.13, 2012, https://doi.org/10.1038/s41386-020-00812-7